Ultrastructural Localization of Secretory Type II Phospholipase A 2 in Atherosclerotic and Nonatherosclerotic Regions of Human Arteries
- 1 April 1998
- journal article
- research article
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 18 (4) , 519-525
- https://doi.org/10.1161/01.atv.18.4.519
Abstract
—We recently reported on the immunolocalization of type II secretory nonpancreatic phospholipase A2 (snpPLA2) in human atherosclerotic lesions. In the present study, we present data on the distribution and ultrastructural localization of snpPLA2 in adjacent nonatherosclerotic and atherosclerotic regions of human arteries. Electron microscopy (EM) of immunogold labeling techniques with a monoclonal antibody was used to analyze arterial tissue. The human specimens analyzed were obtained from autopsy and surgery cases. The results with EM showed a stronger snpPLA2 immunoreactivity in regions of arteries with atherosclerotic lesions than in regions without lesions from the same individual. snpPLA2 immunoreactivity was stronger in the arterial intima of atherosclerotic than of nonatherosclerotic tissue. EM-immunogold examination revealed that the majority of snpPLA2 was localized along the extracellular matrix, associated with collagen fibers and other extracellular matrix structures. Intracellular snpPLA2 was observed in electron-dense vesicles in intimal cells. snpPLA2 was also found in contact with large, extracellular lipid droplets. These results support the hypothesis that extracellular snpPLA2 is localized at sites where it may hydrolyze phospholipids from lipoproteins and lipid aggregates retained in the extracellular matrix of the arterial wall. This may be a mechanism for in situ release of proinflammatory lipids, free fatty acids, and lysophosphatidylcholine in regions of apolipoprotein B accumulation, which are abundant in atherosclerotic lesions.Keywords
This publication has 44 references indexed in Scilit:
- Binding of Human Phospholipase A2 Type II to ProteoglycansJournal of Biological Chemistry, 1996
- Analysis of Lysophophatidylcholine-Induced Endothelial DysfunctionJournal of Cardiovascular Pharmacology, 1996
- Role of lysophosphatidylcholine in the inhibition of endothelial cell motility by oxidized low density lipoprotein.Journal of Clinical Investigation, 1996
- Lysophosphatidic Acid, a Multifunctional Phospholipid MessengerJournal of Biological Chemistry, 1995
- Human Neutrophils Store Type II 14-kDa Phospholipase A2 in Granules and Secrete Active Enzyme in Response to Soluble StimuliBiochemical and Biophysical Research Communications, 1995
- Inhibition of human secretory class II phospholipase A2 by heparinEuropean Journal of Biochemistry, 1994
- Phosphatidylcholine breakdown and signal transductionBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1994
- Are Events After Endotoxemia Related to Circulating Phospholipase A2 ?Annals of Surgery, 1994
- Cytokine-stimulated secretion of group II phospholipase A2 by rat mesangial cells. Its contribution to arachidonic acid release and prostaglandin synthesis by cultured rat glomerular cells.Journal of Clinical Investigation, 1993
- Isolation of low density lipoprotein from atherosclerotic vascular tissue of Watanabe heritable hyperlipidemic rabbits.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1988